Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Peer reviewer login
  • Journal club
  • Alerts
  • Subscriptions

An unusual case of unilateral hyperlucent lung

Richa Mittal, Rohit Kumar, A. J. Mahendran, Manas Mengar, Shibdas Chakrabarti
Breathe 2020 16: 200071; DOI: 10.1183/20734735.0071-2020
Richa Mittal
Dept of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Richa Mittal
Rohit Kumar
Dept of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dr.rohitkumar@mail.com
A. J. Mahendran
Dept of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manas Mengar
Dept of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shibdas Chakrabarti
Dept of Pulmonary, Critical Care and Sleep Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Differential diagnoses of unilateral hyperlucent lung are expansive, ranging from soft tissue to pulmonary parenchyma. A systematic approach to interpretation of radiography guides us in quick localisation of the anatomical site of involvement. https://bit.ly/3fNy4vT

A 38-year-old male, clerk by profession, presented to our institute with complaints of cough without expectoration and difficulty in breathing for 3 years. The dyspnoea was persistent, exertional and had progressively worsened over this period of 3 years, it was currently grade 2 on the modified Medical Research Council (mMRC) grading. He was a never-smoker and there was no history of environmental tobacco smoke or exposure to noxious particles or history of illicit drug abuse. Past medical and surgical history was not significant. There was no history of significant respiratory infections during childhood and there was no history of anyone in his family with similar complaints.

He was tachypnoeic and oxygen saturation was 94% on room air. There were decreased chest movements on the left side with a hyperresonant note on percussion in the mammary, axillary and infra axillary areas anteriorly and in all the areas of the chest posteriorly. On auscultation, decreased air intensity on the same side was heard. Chest radiography was carried out (figure 1).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

Posteroanterior chest radiograph showing increased translucency of the left hemithorax with displacement of mediastinal structures to the contralateral side.

Task 1

What is the main site of abnormality seen in the chest radiograph?

  • a) Pleural abnormality

  • b) Parenchymal abnormality

  • c) Chest wall abnormality

  • d) Airway abnormality

Answer 1

b. Parenchymal abnormality. The chest radiograph shows unilateral hyperlucent lung with mediastinal shift. There are attenuated lung markings in the left hemithorax with evidence of hyperinflation (low lying and flattened diaphragm) and shift of mediastinum to the right side. In contrast to pleural abnormality (pneumothorax), there is no line of pleural demarcation. There is presence of vascular markings, although attenuated, in the hyperlucent area.

A parenchymal defect manifesting as unilateral hyperlucent lung is usually due to two processes, i.e. obstructive and compensatory hyperinflation [1]. The findings in the current chest radiograph points towards obstructive hyperinflation as there is a large size hyperinflated lung field with narrowed vascular markings, the cause of which can be segregated based on the size of the diseased hemithorax. A small hilar shadow along with small sized affected lobes is characteristically seen in Swyer–James–MacLeod syndrome (SJMS), whereas large lung volumes are seen in cases of congenital lobar emphysema (CLE), bronchial atresia, and bullous emphysema [2].

Further evaluation was undertaken, and pulmonary function tests were suggestive of severe airflow limitation: forced vital capacity (FVC) 2.35 L (61% predicted), forced expiratory volume in 1 s (FEV1) 1.17 L (36% predicted), with a FEV1/FVC ratio of 49.7%. Arterial blood gas analysis revealed hypoxaemia (arterial oxygen tension 71.3 mmHg).

Task 2

How would you like to proceed?

  • a) Computed tomography (CT) scan of the chest

  • b) Bronchoscopy

  • c) Ventilation perfusion scans

  • d) Pulmonary function tests with lung volumes

Answer 2

a and b. Both a CT scan of the chest and bronchoscopy. Chest radiography in the current case showed signs of obstructive hyperinflation, but there are various conditions that can cause this such as foreign body aspiration, inflammatory bronchial strictures, endobronchial tumours, bronchial atresia, SJMS, congenital lobar emphysema, unilateral bullous emphysema or cystic lung diseases, and extrinsic bronchial compression due to mediastinal lesions. Common to all these conditions are the characteristic radiographic finding, i.e. the presence of a hyperlucent lung, with spreading and narrowing of the pulmonary vessels and on expiratory films there is no appreciable change in the volume of the affected lung, whereas the contralateral normal lung decreases in volume [3]. Thoracic CT is essential for diagnosis of the underlying cause and the majority of these conditions can be ruled out by performing bronchoscopy in addition to a CT scan. For example, evidence of blind-ending bronchi and mucoceles seen characteristically in bronchial atresia, visualisation of any intrinsic or extrinsic compression of the bronchus or presence of any strictures or bronchomalacia which can lead to signs of obstructive hyperinflation. Another significant differential is SJMS which is secondary to recurrent bronchiolitis in infancy and childhood and is characterised by diminished vascularity but a small hemithorax with associated abnormalities, such as bronchiectasis [2].

Apart from the abovementioned conditions of unilateral hyperlucent lung associated with air trapping, another important differential of CLE is congenital pulmonary airway malformation (CPAM), which can be differentiated by the presence of multiple cysts within the hyperlucent lung. Bullous emphysema is usually seen in smokers with concomitant marijuana abuse and commonly has bilateral involvement. Finally, CLE can mimic pneumothorax as both the conditions have similar findings on clinical examination and radiographically there is shift of mediastinum to the side opposite to the hyperlucent lung. The two can be distinguished by the presence of vascular markings inside the hyperlucent area in the former [1, 3].

Hence to evaluate the anatomy and associated abnormalities of the affected lobe, CT scan of chest was carried out, which showed emphysema of the left lower lobe with mediastinal shift to the right side and compression of left upper lobe, with rest of the parenchyma being normal (figures 2 and 3). Fibre-optic bronchoscopy was carried out to rule out any intraluminal obstruction and it revealed normal bronchial anatomy and patent airways. α1-antitrypsin level was normal. Echocardiography showed no valvular lesion or shunts, and ejection fraction was 55%.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2

Axial section of the chest CT at the level of the main carina showing shift of mediastinum to right side and hyperinflation of left lower lobe and compression of adjacent parenchyma.

Figure 3
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3

a and b) Coronal sections of the chest CT showing hyperinflation of left lower lobe with displacement of oblique fissure and compression of adjacent upper lobe. Vascular markings are noted inside the hyperinflated lungs and are attenuated.

A definitive diagnosis of CLE of the left lower lobe was made as clinical and radiological features were absolute for the disease and normal bronchoscopy additionally ruled out other causes of obstructive hyperinflation.

Task 3

Which is the most common lobe involved in CLE?

  • a) Right upper lobe

  • b) Right middle lobe

  • c) Left upper lobe

  • d) Left lower lobe

Answer 3

c. Left upper lobe. The left upper lobe is most often affected (43%) followed by right middle lobe (32%) and right upper lobe (20%). Lower lobe involvement is very rare. Typically, it is unilateral with only a couple of cases reported to have multilobar or bilateral involvement [4, 5]. As remarked previously, this report describes an atypical presentation of CLE with its first manifestation in fourth decade of life and involvement of the left lower lobe, which is also known to be very rare.

Task 4

What is the best treatment option for this condition?

  • a) Bronchodilators

  • b) Inhaled corticosteroids

  • c) Endobronchial valve placement

  • d) Surgical resection/lobectomy

Answer 4

d. Surgical resection/lobectomy. In infants with respiratory distress, the treatment of choice remains resection, usually lobectomy with promising results [4, 6]. Newer and nonsurgical options, such as an endobronchial valve, have been tried in a few cases and appears to be a potential option in selected patients [7]. Evidence of adults presenting with CLE is sparse and hence management of such patients remains unclear and is mainly based on severity of symptoms and radiological features.

The patient was given a trial of inhaled bronchodilators. He had relief of symptoms and there was no limitation of activity, therefore the patient was continued on conservative management. The patient is in routine follow-up, with no clinical progression of his symptoms to date.

Discussion

CLE is a rare bronchopulmonary malformation characterised by overdistension of the affected lobe due to massive air trapping and accompanying damage to septa leading to compression and displacement of adjacent normal lung tissue [4]. It was first reported by Gross and Lewis in 1954 [8]. It has a prevalence of 4.5 per 100 000, with one third of cases presenting in neonatal period itself and almost all by 6 months of age [9]. First presentation in adulthood is much more uncommon [4, 10].

The aetiology of this abnormality is still unknown, although a variety of causes have been proposed which cause obstruction of the developing airway, leading to ball valve obstruction and air trapping causing emphysema, such as cartilaginous dysplasia of bronchi, vascular anomalies, kinking of the bronchioles, compression by large lymph nodes, mucus plugs, alveolar disease and bronchial stenosis [11, 12]. The most accepted among the theories are bronchial cartilage defects like hypoplasia, flaccid tissue, or absence of cartilage. It occurs twice as often in males as in females [12]. In most cases, the left upper lobe is affected followed by right middle lobe, right upper lobe and lower lobes.

On physical examination, a hyperresonant note on percussion in the afflicted lobe is noted and breath sounds are diminished in that part of the lung. Although rare, wheezing and rhonchus can also be heard.

The most common abnormality seen on spirometry is an obstructive pattern, although it can be normal in mild or asymptomatic cases [10]. Fundamental to diagnosis are the radiological features which are markedly increased volume of the affected lobe, depression of the ipsilateral diaphragm, compression of the surrounding lung parenchyma and displacement of mediastinum to contralateral side suggesting over-inflation and air trapping in the affected lobe. Despite the attenuation of vascular markings in the affected lobe, they are well maintained and can be traced to the periphery of the lung. Chest radiography and CT scan are required to establish the diagnosis. Other adjunctive investigations are a ventilation/perfusion scan, which depicts obstructed and delayed ventilation and slightly decreased perfusion of the affected lobe, and magnetic resonance imaging, which can demonstrate any vascular lesion causing external compression [10, 13].

Diagnosis of CLE can pose a challenge for physicians as there are various conditions that can cause unilateral hyperlucent lung associated with air trapping (also known as obstructive hyperinflation). A review of the literature indicates that some patients were erroneously diagnosed with pneumothorax initially and therefore a careful reading of the radiograph is warranted [14]. A unilateral hyperlucent radiograph can itself be due to a wide variety of reasons and a structured approach can help us to narrow the list of differentials. First and foremost, we must look for the technical quality and rotation of film as it can falsely lead to hyperlucent lung on the side to which the patient is rotated. A systematic look into the details of the radiograph, moving from outside to inside can help us in localising the anatomical site of the abnormality, a summary of which is detailed in table 1.

View this table:
  • View inline
  • View popup
Table 1

Differential diagnosis of unilateral hyperlucent lung

CLE is known to be associated with congenital heart diseases in about 20% cases. Most common cardiac anomalies are left to right shunts (mainly ventricular septal defects), tetralogy of Fallot, and patent ductus arteriosus. Hence, two-dimensional echocardiography is an essential component in baseline evaluation of CLE patients [15, 16]. A strong suspicion, detailed history, chest CT and bronchoscopy are required to clinch the diagnosis and rule out the resembling diseases.

The treatment of choice for CLE depends on severity of disease [16]. The medical management of the disease includes inhaled bronchodilators and surgical treatment usually involves lobectomy [4, 6, 17]. Recently nonsurgical approaches such as endobronchial valve placement have been attempted in a few cases with promising results and this appears to be a potential future option with a less invasive approach [7]. Fierro et al. [18] performed a retrospective study on six infants to determine if surgical removal of the lobe would improve pulmonary function by inserting a balloon catheter in the affected lobe with bedside bronchoscopy. They postulated that temporary balloon occlusion of the lobe can assist in decision making for a lobectomy in symptomatic infants by monitoring oxygenation, gas exchange and radiological parameters after the occlusion [18].

Similar results were seen when surgical and medical management were compared in a long-term follow-up study of CLE patients [16]. Hence, a severely symptomatic patient or progression of disease should be managed with surgical intervention whereas conservative management can be tried with close follow-up for mild or asymptomatic disease [16, 19, 20].

Footnotes

  • Conflict of interest: R. Mittal has nothing to disclose.

  • Conflict of interest: R. Kumar has nothing to disclose.

  • Conflict of interest: A.J. Mahendran has nothing to disclose.

  • Conflict of interest: M. Mengar has nothing to disclose.

  • Conflict of interest: S. Chakrabarti has nothing to disclose.

  • Received April 24, 2020.
  • Accepted November 26, 2020.
  • Copyright ©ERS 2021
http://creativecommons.org/licenses/by-nc/4.0/

Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Noh HJ,
    2. Oh YW,
    3. Choi EJ, et al.
    Unilateral hyperlucency of the lung: a systematic approach to accurate radiographic interpretation. J Korean Radiol Soc 2002; 47: 615–623. doi:10.3348/jkrs.2002.47.6.615
    OpenUrl
  2. ↵
    1. Marchevsky AM,
    2. Guintu R,
    3. Koss M, et al.
    Swyer–James (MacLeod) syndrome with placental transmogrification of the lung: a case report and review of the literature. Arch Pathol Lab Med 2005; 129: 686–689.
    OpenUrlPubMed
  3. ↵
    1. Pike D,
    2. Mohan S,
    3. Ma W, et al.
    Pulmonary imaging abnormalities in an adult case of congenital lobar emphysema. J Radiol Case Rep 2015; 9: 9–15.
    OpenUrl
  4. ↵
    1. Hendren WH,
    2. McKee DM
    . Lobar emphysema of infancy. J Pediatr Surg 1966; 1: 24–29. doi:10.1016/0022-3468(66)90005-4
    OpenUrlCrossRef
  5. ↵
    1. Monin P,
    2. Didier F,
    3. Vert P, et al.
    Giant lobar emphysema: neonatal diagnosis. PediatrRadiol 1979; 8: 259–260.
    OpenUrl
  6. ↵
    1. Perry Y,
    2. Espiritu M,
    3. Schroeder E
    . Congenital lobar emphysema in adult treated with video assisted thoracoscopic lobectomy. J Pulmon Respir Med 2013; S14: 003. doi:10.4172/2161-105X.S14-003
    OpenUrl
  7. ↵
    1. Wood DE,
    2. Nader DA,
    3. Springmeyer SC, et al.
    The IBV Valve trial: a multicenter, randomized, doubleblind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol 2014; 21: 288–297. doi:10.1097/LBR.0000000000000110
    OpenUrl
  8. ↵
    1. Lister J,
    2. Irving IM
    1. Irving IM
    . Malformations and acquired lesions of lungs, pleura and mediastinum. In:Lister J, Irving IM, eds. Neonatal Surgery. London, Butterworth & Co Ltd, 1990; pp. 265–271.
  9. ↵
    1. Khalid M,
    2. Saleemi S,
    3. Khan B
    . Congenital lobar emphysema in adult: a rare case report. Respiratory Medicine CME 2010; 3: 150–152. doi:10.1016/j.rmedc.2009.09.010
    OpenUrl
  10. ↵
    1. Sadaqat M,
    2. Malik JA,
    3. Karim R
    . Congenital lobar emphysema in an adult. Lung India 2011; 28: 67–69. doi:10.4103/0970-2113.76307
    OpenUrlPubMed
  11. ↵
    1. Chinya A,
    2. Pandey PR,
    3. Sinha SK, et al.
    Congenital lobar emphysema: pitfalls in diagnosis. Lung India 2016; 33: 317–319. doi:10.4103/0970-2113.180883
    OpenUrl
  12. ↵
    1. Murray GF
    . Congenital lobar emphysema. Surg Gynecol Obstet 1967; 124: 611–625.
    OpenUrlPubMed
  13. ↵
    1. Karnak I,
    2. Senocak ME,
    3. Ciftci AO, et al.
    Congenital lobar emphysema: diagnostic and therapeutic considerations. J Pediatr Surg 1999; 34: 1347–1351. doi:10.1016/S0022-3468(99)90009-X
    OpenUrlCrossRefPubMed
  14. ↵
    1. Subramanyam R,
    2. Costandi A,
    3. Mahmoud M
    . Congenital lobar emphysema and tension emphysema. J Clin Anesth 2016; 29: 17–18. doi:10.1016/j.jclinane.2015.10.008
    OpenUrl
  15. ↵
    1. Cataneo DC,
    2. Rodrigues OR,
    3. Hasimoto EN, et al.
    Congenital lobar emphysema: 30-year case series in two university hospitals. J Bras Pneumol 2013; 39: 418–426. doi:10.1590/S1806-37132013000400004
    OpenUrlCrossRefPubMed
  16. ↵
    1. Demir OF,
    2. Hangul M,
    3. Kose M
    . Congenital lobar emphysema: diagnosis and treatment options. Int J Chron Obstruct Pulmon Dis 2019; 14: 921–928. doi:10.2147/COPD.S170581
    OpenUrl
  17. ↵
    1. Ulku R,
    2. Onat S,
    3. Ozçelik C
    . Congenital lobar emphysema: differential diagnosis and therapeutic approach. Pediatr Int 2008; 50: 658–661. doi:10.1111/j.1442-200X.2008.02630.x
    OpenUrlCrossRefPubMed
  18. ↵
    1. Fierro JL,
    2. Hysinger EB,
    3. Piccione J, et al.
    The role of selective balloon occlusion in preoperative planning for infant pulmonary lobar hyperinflation. Pediatr Allergy Immunol Pulmonol 2018; 31: 186–190. doi:10.1089/ped.2017.0827
    OpenUrl
  19. ↵
    1. Mei-Zahav M,
    2. Konen O,
    3. Manson DC, et al.
    Is congenital lobar emphysema a surgical disease? J Pediatr Surg 2006; 41: 1058–1061. doi:10.1016/j.jpedsurg.2006.02.011
    OpenUrlCrossRefPubMed
  20. ↵
    1. King N,
    2. Ramesh SS,
    3. Essandoh M, et al.
    Near complete obliteration of the left hemithorax by congenital lobar emphysema in an adult. Ann Thorac Surg 2017; 104: 367–369. doi:10.1016/j.athoracsur.2017.06.068
    OpenUrl
PreviousNext
Back to top
Vol 16 Issue 4 Table of Contents
Breathe: 16 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
An unusual case of unilateral hyperlucent lung
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
An unusual case of unilateral hyperlucent lung
Richa Mittal, Rohit Kumar, A. J. Mahendran, Manas Mengar, Shibdas Chakrabarti
Breathe Dec 2020, 16 (4) 200071; DOI: 10.1183/20734735.0071-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
An unusual case of unilateral hyperlucent lung
Richa Mittal, Rohit Kumar, A. J. Mahendran, Manas Mengar, Shibdas Chakrabarti
Breathe Dec 2020, 16 (4) 200071; DOI: 10.1183/20734735.0071-2020
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung imaging
  • Respiratory clinical practice
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Expert opinion

  • Lung cancer screening by volume CT
  • In pursuit of the primary
  • A rare complication in a case of nonsmall cell lung carcinoma
Show more Expert opinion

Case report

  • Bilateral mediastinal lymphadenopathy with cough and shortness of breath
  • Recurrent bilateral lung infiltrates in a patient with UC
  • A pregnant woman with severe dyspnoea
Show more Case report

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About Breathe

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Intructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 1810-6838
Online ISSN: 2073-4735

Copyright © 2023 by the European Respiratory Society